4.7 Article

The Effects of Antidepressant Treatment on Resting-State Functional Brain Networks in Patients With Major Depressive Disorder

Journal

HUMAN BRAIN MAPPING
Volume 36, Issue 2, Pages 768-778

Publisher

WILEY
DOI: 10.1002/hbm.22663

Keywords

depression; antidepressant; resting-state fMRI; graph theory; connectomics

Funding

  1. 12th Five-year-plan of National Key Technologies R&D Program of China [2011ZX09302-004]
  2. National Key Basic Research Program of China [2014CB846102, 2013CB531305, 2012CB720704]
  3. Research Fund for the Doctoral Program of Higher Education of China [20130001110106]
  4. Natural Science Foundation of China [81030028, 31221003, 81401479]
  5. National Science Fund for Distinguished Young Scholars [81225012]

Ask authors/readers for more resources

Although most knowledge regarding antidepressant effects is at the receptor level, the neurophysiological correlates of these neurochemical changes remain poorly understood. Such an understanding could benefit from elucidation of antidepressant effects at the level of neural circuits, which would be crucial in identifying biomarkers for monitoring treatment efficacy of antidepressants. In this study, we recruited 20 first-episode drug-naive major depressive disorder (MDD) patients and performed resting-state functional magnetic resonance imaging (MRI) scans before and after 8 weeks of treatment with a selective serotonin reuptake inhibitorescitalopram. Twenty healthy controls (HCs) were also scanned twice with an 8-week interval. Whole-brain connectivity was analyzed using a graph-theory approachfunctional connectivity strength (FCS). The analysis of covariance of FCS was used to determine treatment-related changes. We observed significant group-by-time interaction on FCS in the bilateral dorsomedial prefrontal cortex and bilateral hippocampi. Post hoc analyses revealed that the FCS values in the bilateral dorsomedial prefrontal cortex were significantly higher in the MDD patients compared to HCs at baseline and were significantly reduced after treatment; conversely, the FCS values in the bilateral hippocampi were significantly lower in the patients at baseline and were significantly increased after treatment. Importantly, FCS reduction in the dorsomedial prefrontal cortex was significantly correlated with symptomatic improvement. Together, these findings provided evidence that this commonly used antidepressant can selectively modulate the intrinsic network connectivity associated with the medial prefrontal-limbic system, thus significantly adding to our understanding of antidepressant effects at a circuit level and suggesting potential imaging-based biomarkers for treatment evaluation in MDD. Hum Brain Mapp 36:768-778, 2015. (c) 2014 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available